Eve Burstein
Stock Analyst at Bernstein
(4.58)
# 981
Out of 5,133 analysts
151
Total ratings
72.7%
Success rate
23.2%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTR Avantor | Reiterated: Hold | n/a | $15.54 | - | 16 | Nov 13, 2026 | |
| ILMN Illumina | Reiterated: Hold | n/a | $207.01 | - | 20 | Nov 13, 2026 | |
| RVTY Revvity | Rated: Hold | $120 → $160 | $154.39 | +3.63% | 16 | Nov 13, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Hold | n/a | $700.22 | - | 20 | Nov 13, 2026 | |
| WAT Waters | Reiterated: Buy | $450 → $535 | $460.25 | +16.24% | 18 | Nov 13, 2026 | |
| A Agilent Technologies | Rated: Buy | $180 | $173.96 | +3.47% | 18 | Oct 19, 2026 | |
| GH Guardant Health | Rated: Buy | $210 | $151.70 | +38.43% | 14 | Oct 19, 2026 | |
| NTRA Natera | Rated: Buy | $365 | $319.09 | +14.39% | 14 | Oct 19, 2026 | |
| BIIB Biogen | Reiterated: Buy | $236 | $253.40 | -6.87% | 1 | Sep 25, 2026 | |
| IMVT Immunovant | Reiterated: Hold | $37 | $34.18 | +8.25% | 1 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $756 | $955.47 | -20.88% | 1 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $39.53 | +3.72% | 1 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $1.7 | $1.96 | n/a | 10 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €194.00 | €290.50 | n/a | 1 | Jan 6, 2025 |
Avantor
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.54
Upside: -
Illumina
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $207.01
Upside: -
Revvity
Nov 13, 2026
Rated: Hold
Price Target: $120 → $160
Current: $154.39
Upside: +3.63%
Thermo Fisher Scientific
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $700.22
Upside: -
Waters
Nov 13, 2026
Reiterated: Buy
Price Target: $450 → $535
Current: $460.25
Upside: +16.24%
Agilent Technologies
Oct 19, 2026
Rated: Buy
Price Target: $180
Current: $173.96
Upside: +3.47%
Guardant Health
Oct 19, 2026
Rated: Buy
Price Target: $210
Current: $151.70
Upside: +38.43%
Natera
Oct 19, 2026
Rated: Buy
Price Target: $365
Current: $319.09
Upside: +14.39%
Biogen
Sep 25, 2026
Reiterated: Buy
Price Target: $236
Current: $253.40
Upside: -6.87%
Immunovant
Sep 25, 2026
Reiterated: Hold
Price Target: $37
Current: $34.18
Upside: +8.25%
Sep 25, 2026
Reiterated: Hold
Price Target: $756
Current: $955.47
Upside: -20.88%
Sep 25, 2026
Reiterated: Buy
Price Target: $41
Current: $39.53
Upside: +3.72%
Aug 8, 2025
Reiterated: Buy
Price Target: $1.5 → $1.7
Current: $1.96
Upside: n/a
Jan 6, 2025
Reiterated: Sell
Price Target: €194.00
Current: €290.50
Upside: n/a